ClinConnect ClinConnect Logo
Search / Trial NCT02984007

PROMOtion of VAccination in Canada (PromovaC Study)

Launched by UNIVERSITÉ DE SHERBROOKE · Dec 1, 2016

Trial Information

Current as of June 29, 2025

Completed

Keywords

ClinConnect Summary

OBJECTIVES

Main objective: To evaluate the impact of the motivational interviewing (MI) intervention on parents' intention to vaccinate their infant and their vaccine hesitancy (VH) score in a Pan-Canadian context. In order to explore differences in the intervention's impact according to cultural and organizational factors, all analysis will also be conducted at the level of each center.

Specific objectives:

1. To assess parents' intention to vaccinate their infant before the intervention and immediately after the intervention, globally and at each center level.
2. To assess parents' VH ...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • All mothers of infants born in 1 of the 6 participating maternity wards.
  • Exclusion Criteria:
  • Mothers aged \<18 years;
  • Mothers who do not speak English or French;
  • Any health situation of the newborn or the mother requiring acute care (i.e. if the newborn needs to be hospitalized in the neonatology unit or if the mother has an incompatible condition for an interview);
  • Mothers who have participated in one of the two studies evaluating the impact of the MI intervention in the Eastern Townships in 2009-2010 and in the province of Quebec in 2014-2015.

About Université De Sherbrooke

The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.

Locations

Halifax, Nova Scotia, Canada

Toronto, Ontario, Canada

Surrey, British Columbia, Canada

Charlottetown, , Canada

Sherbrooke, Quebec, Canada

Vancouver, British Columbia, Canada

Charlottetown, Prince Edward Island, Canada

Patients applied

0 patients applied

Trial Officials

Arnaud Gagneur, MD, PhD

Principal Investigator

Université de Sherbrooke

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials